Interactive impact of childhood maltreatment, depression, and age on cortical brain structure: mega-analytic findings from a large multi-site cohort.


Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
04 2020
Historique:
pubmed: 16 5 2019
medline: 13 4 2021
entrez: 16 5 2019
Statut: ppublish

Résumé

Childhood maltreatment (CM) plays an important role in the development of major depressive disorder (MDD). The aim of this study was to examine whether CM severity and type are associated with MDD-related brain alterations, and how they interact with sex and age. Within the ENIGMA-MDD network, severity and subtypes of CM using the Childhood Trauma Questionnaire were assessed and structural magnetic resonance imaging data from patients with MDD and healthy controls were analyzed in a mega-analysis comprising a total of 3872 participants aged between 13 and 89 years. Cortical thickness and surface area were extracted at each site using FreeSurfer. CM severity was associated with reduced cortical thickness in the banks of the superior temporal sulcus and supramarginal gyrus as well as with reduced surface area of the middle temporal lobe. Participants reporting both childhood neglect and abuse had a lower cortical thickness in the inferior parietal lobe, middle temporal lobe, and precuneus compared to participants not exposed to CM. In males only, regardless of diagnosis, CM severity was associated with higher cortical thickness of the rostral anterior cingulate cortex. Finally, a significant interaction between CM and age in predicting thickness was seen across several prefrontal, temporal, and temporo-parietal regions. Severity and type of CM may impact cortical thickness and surface area. Importantly, CM may influence age-dependent brain maturation, particularly in regions related to the default mode network, perception, and theory of mind.

Sections du résumé

BACKGROUND
Childhood maltreatment (CM) plays an important role in the development of major depressive disorder (MDD). The aim of this study was to examine whether CM severity and type are associated with MDD-related brain alterations, and how they interact with sex and age.
METHODS
Within the ENIGMA-MDD network, severity and subtypes of CM using the Childhood Trauma Questionnaire were assessed and structural magnetic resonance imaging data from patients with MDD and healthy controls were analyzed in a mega-analysis comprising a total of 3872 participants aged between 13 and 89 years. Cortical thickness and surface area were extracted at each site using FreeSurfer.
RESULTS
CM severity was associated with reduced cortical thickness in the banks of the superior temporal sulcus and supramarginal gyrus as well as with reduced surface area of the middle temporal lobe. Participants reporting both childhood neglect and abuse had a lower cortical thickness in the inferior parietal lobe, middle temporal lobe, and precuneus compared to participants not exposed to CM. In males only, regardless of diagnosis, CM severity was associated with higher cortical thickness of the rostral anterior cingulate cortex. Finally, a significant interaction between CM and age in predicting thickness was seen across several prefrontal, temporal, and temporo-parietal regions.
CONCLUSIONS
Severity and type of CM may impact cortical thickness and surface area. Importantly, CM may influence age-dependent brain maturation, particularly in regions related to the default mode network, perception, and theory of mind.

Identifiants

pubmed: 31084657
pii: S003329171900093X
doi: 10.1017/S003329171900093X
pmc: PMC9254722
mid: NIHMS1814604
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1020-1031

Subventions

Organisme : NIA NIH HHS
ID : R01 AG058854
Pays : United States
Organisme : Department of Health
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : R01 MH116147
Pays : United States
Organisme : NIBIB NIH HHS
ID : U54 EB020403
Pays : United States
Organisme : NIA NIH HHS
ID : R56 AG058854
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH085734
Pays : United States
Organisme : NIMH NIH HHS
ID : K01 MH097978
Pays : United States
Organisme : NIMH NIH HHS
ID : K01 MH117442
Pays : United States

Références

Arch Gen Psychiatry. 2011 May;68(5):527-33
pubmed: 21536980
Hippocampus. 2004;14(6):742-51
pubmed: 15318332
Mol Psychiatry. 2017 Jun;22(6):900-909
pubmed: 27137745
Neurobiol Stress. 2018 May 06;8:147-157
pubmed: 29888310
Biol Psychiatry. 2012 Feb 15;71(4):286-93
pubmed: 22112927
Depress Anxiety. 1999;9(4):169-74
pubmed: 10431682
Biol Psychiatry. 2010 Nov 1;68(9):832-8
pubmed: 20692648
Neuroimage. 2006 Jul 1;31(3):968-80
pubmed: 16530430
Brain Res. 2006 Aug 11;1105(1):130-42
pubmed: 16650836
Nat Rev Neurosci. 2016 Sep 19;17(10):652-66
pubmed: 27640984
J Neurosci. 1996 May 15;16(10):3534-40
pubmed: 8627386
Am J Psychiatry. 2012 Feb;169(2):141-51
pubmed: 22420036
Am J Psychiatry. 1994 Aug;151(8):1132-6
pubmed: 8037246
Pediatrics. 2016 Mar;137(3):e20154079
pubmed: 26810785
J Neurol. 2015 May;262(5):1255-65
pubmed: 25794861
J Psychiatry Neurosci. 2014 Jan;39(1):50-9
pubmed: 23900024
Nat Rev Neurosci. 2009 Jun;10(6):446-57
pubmed: 19455174
Mol Psychiatry. 2008 Sep;13(9):829, 833-57
pubmed: 18574483
J Psychiatr Res. 2010 Oct;44(13):799-807
pubmed: 20122698
Mol Psychiatry. 2017 Oct;22(10):1455-1463
pubmed: 27217146
Behav Brain Res. 2013 Nov 1;256:529-36
pubmed: 23756137
J Neurobiol. 2001 Nov 15;49(3):245-53
pubmed: 11745662
Neuroimage. 2016 Aug 15;137:165-177
pubmed: 27236083
Cereb Cortex. 2000 Mar;10(3):206-19
pubmed: 10731217
Brain Res. 2006 Sep 19;1110(1):166-74
pubmed: 16879809
Trends Cogn Sci. 2014 Nov;18(11):580-585
pubmed: 25305194
Neuroimage. 2003 Aug;19(4):1835-42
pubmed: 12948738
J Psychiatr Res. 2018 Jan;96:57-64
pubmed: 28965006
Psychol Med. 2018 Apr;48(6):1034-1046
pubmed: 29122037
Arch Pediatr Adolesc Med. 2011 Dec;165(12):1069-77
pubmed: 22147775
Biol Psychiatry. 2014 Aug 15;76(4):297-305
pubmed: 24209775
Trends Cogn Sci. 2011 Feb;15(2):85-93
pubmed: 21167765
Biol Psychiatry. 2014 Oct 15;76(8):629-38
pubmed: 24090797
Brain Struct Funct. 2017 Nov;222(8):3477-3490
pubmed: 28424895
Neuropsychopharmacology. 2016 Jun;41(7):1716-23
pubmed: 26576924
J Neurosci. 1990 Dec;10(12):4035-9
pubmed: 2269895
Neurosci Biobehav Rev. 2014 Nov;47:578-91
pubmed: 25454359
Biol Psychiatry. 2013 Dec 1;74(11):845-52
pubmed: 23954109
PLoS One. 2018 Oct 15;13(10):e0205808
pubmed: 30321243
Neuron. 2002 Jan 31;33(3):341-55
pubmed: 11832223
J Psychiatr Res. 2010 Nov;44(15):1063-8
pubmed: 20447651
Dev Psychopathol. 2017 Aug;29(3):929-940
pubmed: 27424571
Arch Gen Psychiatry. 2008 Oct;65(10):1156-65
pubmed: 18838632
J Cogn Neurosci. 2010 Dec;22(12):2790-803
pubmed: 20044897
J Psychiatr Res. 2017 Mar;86:58-65
pubmed: 27918926
Psychiatry Res Neuroimaging. 2017 Oct 30;268:27-34
pubmed: 28843886
Mol Psychiatry. 2011 Mar;16(3):252-64
pubmed: 20661246

Auteurs

Leonardo Tozzi (L)

Department of Psychiatry and Psychotherapy, Otto von Guericke University, Magdeburg, Germany.
Department of Psychiatry and Behavioral Sciences, Stanford University, California, USA.

Lisa Garczarek (L)

Department of Psychiatry and Psychotherapy, Otto von Guericke University, Magdeburg, Germany.

Deborah Janowitz (D)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.

Dan J Stein (DJ)

SAMRC Unit on Risk & Resilience in Mental Disorders, UCT Department of Psychiatry and Mental Health, Cape Town, South Africa.

Katharina Wittfeld (K)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
German Center for Neurodegenerative Diseases (DZNE), Site Rostock/Greifswald, Germany.

Henrik Dobrowolny (H)

Department of Psychiatry and Psychotherapy, Otto von Guericke University, Magdeburg, Germany.

Jim Lagopoulos (J)

Brain and Mind Centre, University of Sydney, Camperdown, Australia.
Sunshine Coast Mind and Neuroscience - Thompson Institute, Queensland, Australia.

Sean N Hatton (SN)

Brain and Mind Centre, University of Sydney, Camperdown, Australia.

Ian B Hickie (IB)

Brain and Mind Centre, University of Sydney, Camperdown, Australia.

Angela Carballedo (A)

Trinity College Institute of Neuroscience, Trinity College Dublin, Ireland.

Samantha J Brooks (SJ)

SAMRC Unit on Risk & Resilience in Mental Disorders, UCT Department of Psychiatry and Mental Health, Cape Town, South Africa.
School of Natural Sciences and Psychology, Liverpool John Moores University, Liverpool, UK.

Daniella Vuletic (D)

SAMRC Unit on Risk & Resilience in Mental Disorders, UCT Department of Psychiatry and Mental Health, Cape Town, South Africa.

Anne Uhlmann (A)

SAMRC Unit on Risk & Resilience in Mental Disorders, UCT Department of Psychiatry and Mental Health, Cape Town, South Africa.
Department of Psychiatry, University of Vermont, Burlington, VT, USA.

Ilya M Veer (IM)

Division of Mind and Brain Research, Department of Psychiatry and Psychotherapy CCM, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Henrik Walter (H)

Division of Mind and Brain Research, Department of Psychiatry and Psychotherapy CCM, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Robin Bülow (R)

Institute for Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Germany.

Henry Völzke (H)

Institute for Community Medicine, University Medicine Greifswald, and Center of Cardiovascular Research (DZHK), Germany, partner site Greifswald.

Johanna Klinger-König (J)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.

Knut Schnell (K)

Department of General Psychiatry, University Hospital Heidelberg, Germany.
Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany.
Department of Psychiatry and Psychotherapy, Asklepios Fachklinikum Göttingen, Göttingen, Germany.

Dieter Schoepf (D)

Department of Psychiatry and Psychotherapy, University of Bonn, Germany, and Department of Psychiatry and Psychotherapy, Vitos Weil-Lahn, Hesse, Germany.

Dominik Grotegerd (D)

Department of Psychiatry and Psychotherapy, University of Münster, Germany.

Nils Opel (N)

Department of Psychiatry and Psychotherapy, University of Münster, Germany.

Udo Dannlowski (U)

Department of Psychiatry and Psychotherapy, University of Münster, Germany.

Harald Kugel (H)

Institute of Clinical Radiology, University of Münster, Germany.

Elisabeth Schramm (E)

Department of Psychiatry and Psychotherapy, Medical Center, University of Freiburg, Germany.
Psychiatric University Clinic, Basel, Switzerland.

Carsten Konrad (C)

Department of Psychiatry and Psychotherapy, Agaplesion Diakoniklinikum, Rotenburg, Germany.
Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany.

Tilo Kircher (T)

Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany.

Dilara Jüksel (D)

Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany.

Igor Nenadić (I)

Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany.

Axel Krug (A)

Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany.

Tim Hahn (T)

Department of Psychiatry and Psychotherapy, University of Münster, Germany.

Olaf Steinsträter (O)

Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany.
Core Facility Brain Imaging, Faculty of Medicine, Philipps-University of Marburg, Germany.

Ronny Redlich (R)

Department of Psychiatry and Psychotherapy, University of Münster, Germany.

Dario Zaremba (D)

Department of Psychiatry and Psychotherapy, University of Münster, Germany.

Bartosz Zurowski (B)

Center for Integrative Psychiatry, University of Lübeck, Lübeck, Germany.

Cynthia H Y Fu (CHY)

School of Psychology, College of Applied Health and Communities, University of East London, London, UK.
Centre for Affective Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Danai Dima (D)

Department of Psychology, School of Arts and Social Sciences, City, University of London, London, UK.
Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

James Cole (J)

Department of Psychology, School of Arts and Social Sciences, City, University of London, London, UK.

Hans J Grabe (HJ)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.

Colm G Connolly (CG)

Department of Psychiatry & Langley Porter Psychiatric Institute, UCSF Weill Institute for Neurosciences, University of California, San Francisco, USA.
Department of Biomedical Sciences, Florida State UniversityTallahassee, FL, USA.

Tony T Yang (TT)

Department of Psychiatry & Langley Porter Psychiatric Institute, UCSF Weill Institute for Neurosciences, University of California, San Francisco, USA.
Department of Psychiatry, Division of Child and Adolescent Psychiatry, University of California, San Francisco (UCSF), USA.

Tiffany C Ho (TC)

Department of Psychiatry & Langley Porter Psychiatric Institute, UCSF Weill Institute for Neurosciences, University of California, San Francisco, USA.
Department of Psychology and Department of Psychiatry & Behavioral Sciences, Stanford University, Stanford, CA, USA.

Kaja Z LeWinn (KZ)

Department of Psychiatry & Langley Porter Psychiatric Institute, UCSF Weill Institute for Neurosciences, University of California, San Francisco, USA.
Department of Psychiatry, Division of Child and Adolescent Psychiatry, University of California, San Francisco (UCSF), USA.

Meng Li (M)

Leibniz Institute for Neurobiology, Magdeburg, Germany.

Nynke A Groenewold (NA)

SAMRC Unit on Risk & Resilience in Mental Disorders, UCT Department of Psychiatry and Mental Health, Cape Town, South Africa.

Lauren E Salminen (LE)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of University of California, Marina del Rey, CA, USA.

Martin Walter (M)

Department of Psychiatry and Psychotherapy, Otto von Guericke University, Magdeburg, Germany.
Leibniz Institute for Neurobiology, Magdeburg, Germany.
Department of Psychiatry and Psychotherapy, University of Tuebingen, Germany.

Alan N Simmons (AN)

VA San Diego Healthcare, San Francisco, CA, USA.
School of Medicine, Department of Psychiatry and Human Behavior, University of California, Irvine, CA, USA.

Theo G M van Erp (TGM)

Clinical Translational Neuroscience Laboratory, Department of Psychiatry and Human Behavior, University of California, Irvine, CA, USA.

Neda Jahanshad (N)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of University of California, Marina del Rey, CA, USA.

Bernhard T Baune (BT)

Department of Psychiatry and Psychotherapy, University of Münster, Germany.
Discipline of Psychiatry, School of Medicine, University of Adelaide, SA5005Adelaide, Australia.
Department of Psychiatry, Melbourne Medical School, The University of Melbourne, VIC3010Melbourne, Australia.
The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, Australia.

Nic J A van der Wee (NJA)

Department of Psychiatry, Leiden Institute for Brain and Cognition, Leiden University Medical Center, Leiden, The Netherlands.

Marie-Jose van Tol (MJ)

Department of Biomedical Sciences of Cells and Systems, Cognitive Neuroscience Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Brenda W J H Penninx (BWJH)

Department of Psychiatry and Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.

Derrek P Hibar (DP)

Clinical Translational Neuroscience Laboratory, Department of Psychiatry and Human Behavior, University of California, Irvine, CA, USA.

Paul M Thompson (PM)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of University of California, Marina del Rey, CA, USA.

Dick J Veltman (DJ)

Department of Psychiatry and Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.

Lianne Schmaal (L)

Orygen, The National Centre of Excellence in Youth Mental Health, Melbourne, Australia.
Centre for Youth Mental Health, The University of Melbourne, Melbourne, Australia.

Thomas Frodl (T)

Department of Psychiatry and Psychotherapy, Otto von Guericke University, Magdeburg, Germany.
Brain and Mind Centre, University of Sydney, Camperdown, Australia.
German Center of Neurodegenerative Diseases (DZNE), Site Magdeburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH